With more clinical candidates being explored for niche indications, orphan drugs, and for indications with a rapid clinical endpoint, the pathway to later clinical phases is short and there’s not enough time to perform bridging studies. Striking the right balance of speed, quality, risk, and investment allows you to shorten drug development timelines and work with efficiency. In this webinar, you’ll learn strategies that will bring success in early development for oral solid dosage forms and for injectable formats. Click here to register.
This article shares some tips to help you avoid buyer’s remorse and make an educated decision about which instrument to purchase. These tips provide you with the tools to make an informed decision when purchasing a cell sorter.
A discussion on potential mechanisms of increased absorption with lipid formulations, screening tools used during the development of these formulations, scale up, and industrialization considerations.
Foundations Of Biopharma Finance With Smital Shah, MBASmital Shah brings engineering, consulting, and finance experience earned at heavyweights like JP Morgan, Leerink, and Gilead to her role at ProQR Therapeutics. On Business of Biotech, Smital shares her recipe for successful business and finance operations in an emerging biopharma organization. Listen now and subscribe so you never miss an episode.